Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid detection of vancomycin-resistant enterococci.
Edberg SC, Hardalo CJ, Kontnick C, Campbell S. Edberg SC, et al. Among authors: hardalo cj. J Clin Microbiol. 1994 Sep;32(9):2182-4. doi: 10.1128/jcm.32.9.2182-2184.1994. J Clin Microbiol. 1994. PMID: 7814543 Free PMC article.
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R, Greene RE, Hachem R, Hadley S, Herbrecht R, Langston A, Louie A, Ribaud P, Segal BH, Stevens DA, van Burik JA, White CS, Corcoran G, Gogate J, Krishna G, Pedicone L, Hardalo C, Perfect JR. Walsh TJ, et al. Among authors: hardalo c. Clin Infect Dis. 2007 Jan 1;44(1):2-12. doi: 10.1086/508774. Epub 2006 Nov 28. Clin Infect Dis. 2007. PMID: 17143808 Clinical Trial.
Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial.
Robbins JA, Tait D, Huang Q, Dubey S, Crumley T, Cote J, Luk J, Sachs JR, Rutkowski K, Park H, Schwab R, Howitt WJ, Rondon JC, Hernandez-Illas M, O'Reilly T, Smith W, Simon J, Hardalo C, Zhao X, Wnek R, Cope A, Lai E, Annunziato P, Guris D, Stoch SA. Robbins JA, et al. Among authors: hardalo c. EBioMedicine. 2022 Aug;82:104138. doi: 10.1016/j.ebiom.2022.104138. Epub 2022 Jul 6. EBioMedicine. 2022. PMID: 35809371 Free PMC article. Clinical Trial.
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.
Li D, Sabato PE, Guiastrennec B, Ouerdani A, Feng HP, Duval V, De Anda CS, Sears PS, Chou MZ, Hardalo C, Broyde N, Rizk ML. Li D, et al. Among authors: hardalo c. Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0089521. doi: 10.1128/AAC.00895-21. Epub 2021 Sep 13. Antimicrob Agents Chemother. 2021. PMID: 34516243 Free PMC article.
Myelosuppression with Oxazolidinones: Are There Differences?
Hardalo C, Lodise TP, De Anda C. Hardalo C, et al. Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01833-18. doi: 10.1128/AAC.01833-18. Print 2019 Jan. Antimicrob Agents Chemother. 2018. PMID: 30578404 Free PMC article. No abstract available.
13 results